USE OF AN IMPEDED ANDROGEN-DANAZOL-IN MANAGEMENT OF BENIGN BREAST DISORDERS

被引:70
作者
ASCH, RH [1 ]
GREENBLATT, RB [1 ]
机构
[1] MED COLL GEORGIA,DEPT ENDOCRINOL,AUGUSTA,GA 30902
关键词
D O I
10.1016/S0002-9378(16)33237-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:130 / 134
页数:5
相关论文
共 12 条
[1]   ENOVID THERAPY (NORETHYNODREL WITH MESTRANOL) FOR FIBROCYSTIC DISEASE [J].
ARIEL, IM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 117 (04) :453-459
[2]  
DICZFALUSY E, 1961, OESTROGENE BEIM MENS
[3]  
FECHNER RE, 1972, CANCER, V29, P566, DOI 10.1002/1097-0142(197203)29:3<566::AID-CNCR2820290306>3.0.CO
[4]  
2-9
[5]  
GREENBLATT RB, 1971, FERTIL STERIL, V22, P102
[6]  
HILF R, 1973, CANCER RES, V33, P2054
[7]  
LEIS HP, 1970, DIAGNOSIS TREATMENT
[8]   BIOLOGICAL BASIS FOR MANAGEMENT OF BENIGN DISEASE OF BREAST - CASE AGAINST SUBCUTANEOUS MASTECTOMY [J].
PEACOCK, EE .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1975, 55 (01) :14-20
[9]  
RECLUS P, 1883, REV CHIR, V3, P761
[10]  
Taylor HC, 1936, SURG GYNECOL OBSTET, V62, P562